Differential Complete Blood Count for Diagnosis of COVID-19?

Table 4.

Comparison oflaboratory investigations between case and control groups.

Variable Case Group Control Group Total X2 Value P Value (Sig)

Leucopenia Positive 21 (24.1%) 4 (4.7%) 25 (14.5%) 13.284 0.000
(VHS)
Negative 66 (75.9%) 82 (95.3%) 148 (85.5%)

Neutropenia Positive 12 (13.8%) 5 (5.8%) 17 (9.8%) 3.107 0.078
(NS)
Negative 75 (86.2%) 81 (94.2%) 156 (90.2%)

Lymphopenia Positive 53 (60.9%) 21 (24.4%) 74 (42.8%) 23.540 0.000
(VHS)
Negative 34 (39.1%) 65 (75.6%) 99 (57.2%)

Eosinocytopenia Positive 35 (40.2%) 25 (29.1%) 60 (34.7%) 2.378 0.123
(NS)
Negative 52 (59.8%) 61 (70.9%) 113 (65.3%)

Monocytosis Positive 2 (2.3%) 14 (16.3%) 16 (9.2%) 10.071 0.002 (HS)
Negative 85 (97.7%) 72 (83.7%) 157 (90.8%)

High CRP Positive 64 (73.6%) 58 (67.4%) 122 (70.5%) 0.780 0.377
(NS)
Negative 23 (26.4%) 28 (32.6%) 51 (29.5%)

Serum Ferritin Positive 44 (50.6%) 11 (12.8%) 55 (31.8%) 28.473 0.001
(VHS)
Negative 43 (49.4%) 75 (87.2%) 118 (68.2%)

High ALT Positive 25 (28.7%) 7 (8.1%) 32 (18.5%) 12.169 0.000
(VHS)
Negative 62 (71.3%) 79 (91.9%) 141 (81.5%)

High AST Positive 20 (23.0%) 5 (5.8%) 25 (14.5%) 10.319 0.001
(VHS)
Negative 67 (77.0%) 81 (94.2%) 148 (85.5%)

VHS: Very highly Significant NS: Non-Significant HS: Highly Significant.